Purchases and Sales Made in Q2 2024 in Summit Therapeutics Inc. (SMMT)
This table provides information about the institutional ownership of Summit Therapeutics Inc. (SMMT) during Q2 2024. The information is specifically focused on institutions that hold shares of Summit Therapeutics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 09, 2024
Q2 2024
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-189K- 5.98% |
$451K - $2.06M
|
2.96M
$58.7M
|
|
|
May 14, 2025
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-224K- 39.91% |
$535K - $2.44M
|
337K
$6.68M
|
|
|
Aug 13, 2024
Q2 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-227K- 33.3% |
$542K - $2.48M
|
454K
$9M
|
|
|
Aug 13, 2024
Q2 2024
|
Sectoral Asset Management Inc
Montreal, A8 |
SELL
|
- |
-290K- 92.06% |
$693K - $3.17M
|
25K
$496K
|
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-309K- 64.8% |
$739K - $3.38M
|
168K
$3.33M
|
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-355K- 51.32% |
$849K - $3.88M
|
337K
$6.68M
|
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-355K- 51.32% |
$849K - $3.88M
|
337K
$6.68M
|
|
|
Jun 12, 2025
Q2 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-380K- 88.85% |
$908K - $4.15M
|
47.7K
$945K
|
|
|
Aug 13, 2024
Q2 2024
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-484K- 74.49% |
$1.16M - $5.29M
|
166K
$3.29M
|
|
|
Aug 12, 2024
Q2 2024
|
Citigroup Inc
|
SELL
|
- |
-495K- 88.63% |
$1.18M - $5.41M
|
63.6K
$1.26M
|
|
|
Aug 13, 2024
Q2 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-1.92M- 19.59% |
$4.6M - $21M
|
7.9M
$157M
|
|
|
Aug 14, 2024
Q2 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-3.99M- 49.19% |
$9.54M - $43.6M
|
4.12M
$81.7M
|